Fallopian Tube Cancer
📧 Sign up to get email alerts when something new happens for Fallopian Tube Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies [Phase 2]
Phase 2 clinical trial evaluating sequential angiogenic blockade for recurrent Mullerian malignancies, completed with results posted in 2016…
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers [Phase 2]
Phase 2 study evaluating MM-121 (seribantumab) in combination with paclitaxel for platinum-resistant/refractory advanced ovarian, fallopian …
-
CLINICAL_TRIALS withdrawal · 2016-04-20Clinical Trial Update: Femara (Letrozole) Versus Placebo for Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
A Phase 2 trial evaluating letrozole (Femara) versus placebo for ovarian, fallopian tube, or primary peritoneal cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-04-05Clinical Trial Update: Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane [Phase 3]
A Phase 3 trial comparing chemotherapy versus hormonal treatment in platinum-resistant ovarian cancer (including peritoneal and fallopian tu…
-
CLINICAL_TRIALS trial_result · 2016-03-11Clinical Trial Update: Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract [Phase 2]
A Phase 2 clinical trial evaluating a combination chemotherapy regimen in women with endometrial cancer, fallopian tube cancer, ovarian canc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer [Phase 1, Phase 2]
This clinical trial update reports Phase 1/2 results for the combination of ixabepilone and liposomal doxorubicin in advanced ovarian and re…
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission [Phase 2]
A Phase 2 trial of sorafenib for ovarian epithelial cancer, Fallopian tube cancer, and primary peritoneal cancer in patients in their second…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy [Phase 1, Phase 2]
This completed Phase 1/2 trial evaluates hyperthermic intraperitoneal chemotherapy (HIPEC) as first-line therapy for patients with Stage III…
-
CLINICAL_TRIALS withdrawal · 2016-02-17Clinical Trial Update: Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent [Phase 1]
Phase 1 trial of activated T-cell therapy with low-dose aldesleukin and sargramostim for advanced ovarian, fallopian tube, or primary perito…
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 1]
This Phase 1 trial update investigates abdominal radiation plus docetaxel for recurrent or persistent advanced ovarian, fallopian tube, or p…
-
CLINICAL_TRIALS trial_result · 2016-02-04Clinical Trial Update: SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084) [Phase 1]
This is a completed Phase 1 clinical trial update for SCH-58500 in patients with fallopian tube cancer, ovarian cancer, or primary peritonea…
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma [Phase 1]
This Phase 1 trial assesses dose escalation of cisplatin-based hyperthermic intraperitoneal chemotherapy (HIPEC) after surgery in patients w…
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Intravenous and Intraperitoneal Paclitaxel, Intraperitoneal Cisplatin, and Intravenous Bevacizumab for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube Cancer [Phase 2]
Phase 2 clinical trial evaluating a combination of intravenous and intraperitoneal paclitaxel, intraperitoneal cisplatin, and intravenous be…
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer [Phase 1]
A Phase 1 clinical trial evaluating the combination of birinapant and conatumumab in relapsed ovarian and related cancers has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer [Phase 3]
Phase 3 trial evaluating paclitaxel plus carboplatin with or without topotecan in stage IIB to IV ovarian epithelial cancer. The study also …
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating combination chemotherapy in patients with ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal c…
-
CLINICAL_TRIALS research · 2015-12-02Clinical Trial Update: Interactive Educational Website for Women With Ovarian Cancer & Caregivers [EARLY_Phase 1]
This document reports the completion of an EARLY Phase 1 clinical trial evaluating an interactive educational website for women with ovarian…
-
CLINICAL_TRIALS trial_result · 2015-12-01Clinical Trial Update: Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma [Phase 2]
Phase 2 trial evaluating erlotinib in combination with carboplatin and paclitaxel in ovarian and related cancers. The study has completed an…
-
CLINICAL_TRIALS trial_result · 2015-11-09Clinical Trial Update: AZD2171 in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 2]
This update reports results from a Phase 2 study of cediranib (AZD2171) in patients with recurrent ovarian, fallopian tube, or primary perit…
-
CLINICAL_TRIALS trial_result · 2015-10-19Clinical Trial Update: Irinotecan and Bevacizumab for Recurrent Ovarian Cancer [Phase 2]
A Phase 2 study evaluating the combination of irinotecan and bevacizumab in recurrent ovarian cancer (including fallopian tube cancer and pr…
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer [Phase 1]
Phase 1 study of trebananib (AMG 386) in combination with paclitaxel and carboplatin for ovarian cancer, fallopian tube cancer, and primary …
-
CLINICAL_TRIALS trial_result · 2015-08-25Clinical Trial Update: Panitumumab and Gemcitabine in Relapsed Ovarian Cancer [Phase 2]
Phase 2 trial evaluating the combination of panitumumab and gemcitabine in relapsed ovarian, fallopian tube, and primary peritoneal cancers …
-
CLINICAL_TRIALS trial_result · 2015-08-05Clinical Trial Update: Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 3]
This Phase 3 trial evaluated chemotherapy plus surgery for patients with stage III or IV ovarian, fallopian tube, or primary peritoneal canc…
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
A Phase 2 clinical trial evaluating UCN-01 in combination with Topotecan for recurrent, persistent, or progressive advanced ovarian epitheli…
-
CLINICAL_TRIALS trial_result · 2015-07-03Clinical Trial Update: Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors [Phase 2]
A Phase 2 trial evaluating consolidation therapy with bevacizumab (Avastin) with or without erlotinib after induction chemotherapy in advanc…